KMWorld CRM Media Streaming Media Faulkner Speech Technology Unisphere/DBTA
Other ITI Websites
American Library Directory Boardwalk Empire Database Trends and Applications DestinationCRM EContentMag Faulkner Information Services Fulltext Sources Online InfoToday Europe Internet@Schools Intranets Today KMWorld Library Resource Literary Market Place Plexus Publishing Smart Customer Service Speech Technology Streaming Media Streaming Media Europe Streaming Media Producer Unisphere Research

News & Events > NewsBreaks

Back Index Forward
Twitter RSS Feed
Weekly News Digest

February 16, 2004 — In addition to this week's NewsBreaks article and the monthly NewsLink Spotlight, Information Today, Inc. (ITI) offers Weekly News Digests that feature recent product news and company announcements. Watch for additional coverage to appear in the next print issue of Information Today. For other up-to-the-minute news, check out ITIís Twitter account: @ITINewsBreaks.

CLICK HERE to view more Weekly News Digest items.

Wolters Kluwer Adds Drug Analytics Tool

Wolters Kluwer Health's Pharma Solutions division announced Adis R&D Insight (R&DI), a new version of its drug development tool that makes it easy to analyze and evaluate large amounts of data from the database at a single glance. Developed by Wolters Kluwer Health in partnership with AdvanTechnologies, Inc. (aTi), the new Adis tool uses proprietary modeling software to graphically represent key elements from the data. New graphics capabilities include the ability to create pie charts, bar charts, and tables. Users can drill down, change groupings, and re-sort the data using new parameters. R&DI is also available without the Analytics add-on.

R&DI contains profiles for more than 16,000 drugs in development, each with a detailed literature review, a rating based on therapeutic value, and commercial intelligence from Lehman Brothers. The new R&DI eliminates the need for users to export data and manipulate it themselves using external software. According to the company, this ability dramatically reduces the time it takes to search and interpret the data. In some cases, where it used to take 1 to 2 hours to drill down and cull a subset of relevant information, it now takes 30 seconds or less.

R&DI enables the user to analyze data in a variety of ways including:

  • Aggregate groups of data from the R&D Insight dataset
  • Summarize and compare drugs across multiple parameters using a matrix
  • Easily export any dataset to preformatted Microsoft Excel spreadsheets

Source: Wolters Kluwer Health

Send correspondence concerning the Weekly News Digest to NewsBreaks Editor Brandi Scardilli
Comments Add A Comment

              Back to top